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self-reported health status, Activities of Daily Living, and Instru-
mental Activities of Daily Living. However, estimates of the
effect of prescription drug coverage on prescription use that
control for selection are much smaller than those previously
reported. CONCLUSION: Studies that purport to analyze the
effect of drug coverage on utilization or health using observa-
tional data needs to account for selection bias associated with
such coverage.
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OBJECTIVES: To construct an algorithm which converts statis-
tics commonly reported in publications with the SF-12 health
status measure to an average SF-6D preference based score.
METHODS: We used SF-12 data from the 2002 Medical Expen-
ditures Panel Survey. We presumed commonly published sufﬁ-
cient statistics would include average age, sex, physical
component score (PCS), and mental component score (MCS). All
combinations of these variables were used as predictors in
models built with WinBUGS 1.4. Model ﬁt was evaluated with
the Deviance Information Criterion (DIC). The best ﬁt model
was also evaluated using R-square for comparison to other algo-
rithms that convert SF-12 summary scores to preference scores.
RESULTS: We used all respondents with PCS and MCS scores
(n = 20,206). The best ﬁt model included age, sex, PCS, and MCS
as predictor variables (DIC = -67,434). The model was SF-6D =
-0.001544 - 0.002173*female + 0.000144*age + 0.008097*
MCS + 0.00816*PCS. The R-square of this model (0.88) was
substantially better than models that convert to EQ5D summary
scores developed by Lawrence et al (0.61) or Franks et al (0.63
and 0.59) or to HUI Mark 3 summary scores by Franks et al
(0.51) or Sengupta et al (0.55). Because this model does not
include power or interaction terms, knowing the average age,
PCS score, MCS score, and the percent whom are female in a
sample is sufﬁcient to predict an average SF-6D score. The resid-
ual from directly calculated SF6D scores drops dramatically as
group size increases; the standard deviation of residual size is
0.046 for 1 subject, 0.014 for 10 subjects, 0.006 for 50 subjects,
0.005 for 100 subjects, and approaches an asymptote of 0.003
with more than 200 subjects. CONCLUSIONS: Commonly
reported summary statistics from previously published articles
provide sufﬁcient information for estimating an average SF-6D
score without accessing individual level data.
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OBJECTIVES: To compare conceptual models, empirical mea-
surement, and results of alternative methods for measuring
patients’ willingness to trade off severe adverse event risks for
speciﬁed health gains. METHODS: We deﬁne and compare the
theoretical foundations of standard gamble (SG) and multi-
attribute conjoint analysis (CA) methods. SG derives from von
Neumann-Morgenstern expected-utility theory, while CA applies
McFadden random-utility theory to hypothetical choices. We
deﬁne theoretical conditions under which the two methods
provide equivalent health-preference measures, including linear-
ity, separability, and risk-neutrality. We evaluate accepted empir-
ical methods used in SG and CA studies and propose methods
for incorporating risks as CA treatment attributes. We then
compare empirical maximum acceptable-risk estimates from CA
studies of multiple sclerosis and Crohn’s disease patients with
and without restrictive SG assumptions, as well as with pub-
lished SG estimates from other disease interventions. RESULTS:
We ﬁnd that SG can be used to estimate MARs for speciﬁc health
outcomes only by imposing more restrictive assumptions on
patient preferences than CA methods require. We show that CA
methods can be used to test various theoretical restrictions
imposed by the SG assumptions and ﬁnd that risk neutrality and
linearity are rejected statistically in most cases. By imposing SG
assumptions on CA results and by comparing CA results to pub-
lished SG estimates for chronic conditions, we ﬁnd that SG
assumptions increase MAR estimates by 20% to 150% relative
to those obtained by CA methods. CONCLUSIONS: CA
methods can be used to replicate SG tradeoff tasks and to test
the restrictions required to interpret SG estimates as risk-prefer-
ence measures. CA offers a more ﬂexible and conceptually rig-
orous method than SG as conventionally applied for measuring
treatment preferences and risk-beneﬁt tradeoffs. Most impor-
tantly, multiattribute CA methods can more realistically simulate
clinically relevant risk-beneﬁt tradeoff choices to improve the
validity and reliability of preference estimates.
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OBJECTIVES: To document whether there are fundamental
racial differences in patients’ perception of the preference-based
utility assessment for health-related quality of life. METHODS:
Secondary data analysis was conducted using the 2003 Medical
Expenditure Panel Survey (MEPS), a nationally representative
sample of 20,428 people with their concurrent EQ-5D scores
reported. Given the upper-bound of preference-based scores at
1.0, a two-part model was derived to identify the relationship
between race and the preference-based utility score after con-
trolling for individual demographic covariates, comorbidity
proﬁle, and functional and activity limitations. Logit models
were employed to predict the probability of “no problems” for
speciﬁc attribute in EQ-5D. In order to generalize the results to
the whole US population, the complex survey sampling design
of MEPS was taken into account using the speciﬁed sample
weight, variance estimation stratum and primary sampling unit.
RESULTS: Compared with Whites, Blacks were less likely to per-
ceive themselves in full health (utility score of 1.0) by 3.5 per-
centage points (p < 0.01), holding all other factors constant. For
those who did not perceive full health (51%), Blacks on average
perceived themselves 0.037 less than Whites in the utility assess-
ment (p < 0.0001). Even after controlling for education and
income, racial difference remained signiﬁcant. Among the ﬁve
attributes of EQ-5D, self-care was the major contributor of the
racial difference for utility assessment. Anxiety/depression was
the only domain which did not have signiﬁcant difference. CON-
CLUSIONS: This study adds to the literature of health-related
quality of life by providing empirical evidence at the national
level to demonstrate the racial differences for preference-based
utility assessment. Health researchers need to be aware that
Blacks are likely to perceive having a lower health-related quality
